-
June 14, 2012
PDL BioPharma Inc. (PDLI) recently announced that it expects to generate second-quarter 2012 royalty revenues of ...
-
May 08, 2012
PDL BioPharma Inc. (PDLI) posted first quarter earnings of 30 cents per share, above the year-ago figure of 25 cents ...
-
January 02, 2012
A meaningful treatment for Alzheimer's is no longer out of reach. Find out which companies are in the race to find a ...
-
November 01, 2011
Biogen Idec is a go-to name in MS that carries a lot of value. A credible buy for those with longer horizons.
-
April 26, 2011
Teva's stock has taken a beating, but the next five years are likely to be tough.
-
March 30, 2011
VimpelCom is moving aggressively to build a global network of emerging markets.
-
March 09, 2011
Despite its fiscal woes, Ireland' tech story could ultimately become its saving grace.
-
February 09, 2011
Teva's results and outlook will likely leave the stock cooling its heels for a bit in this growth-obsessed market, ...
-
August 26, 2010
In good times more risk can be taken. But for now, let's look at a couple of companies paying shareholders a healthy ...
-
May 31, 2010
Following the pros can lead to sone big earnings in the long run.
-
April 30, 2010
Dividend-paying stocks are good, but what about earnings growth? These stocks have both.
-
April 29, 2010
To find high yields, you have to venture into riskier securities such as stocks, and one sector that has some ...
-
April 26, 2010
Although most technology stocks are growth oriented, these three pay investors a great dividend.
-
March 15, 2010
These four are selling for cheap and paying out big.
-
November 10, 2009
Even after seven straight months of rising markets, there are still pockets of value to be found.
-
October 30, 2009
Four names to watch in the healthcare space as their earnings are released Nov. 3.
-
October 15, 2009
A couple of key investment merits should eventually allow J&J’s share price to increase markedly.
-
July 15, 2009
Investors are waiting for J&J to return to its heyday of double-digit growth.
-
September 05, 2008
Pfizer needs to refresh its pipeline, but taking on a high-risk/high-reward experimental drug could do more harm ...
-
July 14, 2008
AS the economy slows, money often pours into healthcare, biotech and big pharma. This week focuses on Novartis AG ADS.
